About Elinzanetant API
Therapeutic CategoryWomen's Health
CAS Number
929046-33-3
API Technology
Synthetic
Dose Form
Tablets
Dr Reddy's Development Status
Under Development
Mechanism of Action
Elinzanetant is a dual neurokinin-1 and 3 (NK-1 and NK-3) receptor antagonist. It modulates estrogen-sensitive neurons in the hypothalamus, which helps control body heat mechanisms and reduce vasomotor symptoms
Indication
Elinzanetant is indicated for the treatment of moderate-to-severe vasomotor symptoms (VMS) associated with menopause
Related APIs
Elinzanetant
Women's Health
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!